Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decongex Gripe for Common Cold Symptoms
NCT02904304Phase 3Suspended
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Dec 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of paracetamol + chlorphenamine + phenylephrine in common cold (2 arms), sponsored by Aché Laboratórios Farmacêuticos. Primary endpoint: Evaluation of the superiority of Desloratadine + Phenylephrine + Ibuprofen over placebo at 3 hours. Started Dec 2020; status: suspended.
02
Drugs
paracetamol + chlorphenamine + phenylephrine
03
Conditions
common cold
Beyond the preview
Go deeper on NCT02904304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02904304.